Kala Bio (KALA) FCF Margin (QoQ) (2019 - 2022)
Kala Bio (KALA) FCF Margin (QoQ) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Kala Bio | 10.00 Mn | 10.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -252,019.00 |
| Jun 30, 2022 | 54,304.00 |
| Mar 31, 2022 | -25,757.00 |
| Dec 31, 2021 | -64,293.00 |
| Sep 30, 2021 | -14,226.00 |
| Jun 30, 2021 | 28,718.00 |
| Mar 31, 2021 | 17,362.00 |
| Dec 31, 2020 | -21.00 |
| Sep 30, 2020 | 120,669.00 |
| Jun 30, 2020 | -50,272.00 |
| Mar 31, 2020 | -32,415.00 |
| Dec 31, 2019 | 3,379.00 |
| Sep 30, 2019 | -57,585.00 |
| Jun 30, 2019 | 126,369.00 |